From IND to Commercial Reality: Scaling Cell and Gene Therapy Manufacturing
Broadcasted live on Tuesday, September 25, 2026 – 1:00 PM ET Commercializing a cell and gene therapy requires more than scaling a process. It requires the deliberate evolution of a CMC strategy — one that matures from early‑phase agility to commercial robustness, regulatory sustainability, and lifecycle management. In this webinar, we will discuss what sponsors … Continued